Thanks to all who submitted their contributions to IFCC-EFLM EuroMedLab Brussels 2025 Congress!
Deadline expired
Abstract submission is closed!
Abstracts will primarily be presented via poster.
Posters will be displayed in electronic format (e-Posters) on interactive totems.
All the e-Posters will be visible on each totem during congress days.
A limited number of abstracts will be selected also for oral presentation during congress symposia. Authors wishing to compete for these oral communication slots should mark the appropriate field on the on-line abstract-submission form.
General information
Deadline for receipt
Submission is closed. Deadline expired on 22nd January 2025.
Confirmation of receipt
Receipt of the abstract will be acknowledged by e-mail immediately after submission.
Notification of acceptance or rejection
Authors will be notified of acceptance or rejection within 28th February 2025.
Registration
The presenting author of each abstract must register for the congress with “Full Registration” or “Young Registration”.
IMPORTANT: when submitting the abstract, please make sure to indicate as presenting author the person who will register and attend the Congress (no other authors). The presenting author cannot be modified after the submission.
IMPORTANT: when submitting the abstract, please make sure to indicate as presenting author the person who will register and attend the Congress (no other authors). The presenting author cannot be modified after the submission.
Abstract topics
- Accreditation, Patient Safety, Risk management, Quality Assurance, Audit
- Artificial intelligence, clinical decision support and machine learning
- Cardiovascular disease; risk assessment; lipids; lipoproteins; cardiac markers
Clinical Chemistry - Data Science , Digital health, big data and smart technologies
- Demand/test utilization management
- Direct to consumer testing
- Disease specific biomarkers: autoimmune, bone, cardiac, cancer, diabetes, neurological, sepsis, traumatic brain injury, …
- Emerging & Analytical technologies, applications and limitations
- Emerging biomarkers (-omics type, …)
- Endocrinology
- Evidence based medicine, including Guidelines
- Genetic diseases
- Geriatric testing
- Green laboratories
- Healthcare reform: from curative to preventive
- Hematology and hemostasis
- Immunology
- Kidney diseases and transplantation, urinalysis, urinary biomarkers
- Laboratory consolidation, Total lab automation and process design
- Laboratory Information Systems and globalization of NPU
- Laboratory Management, Medical leadership
- Metabolic diseases
- Metrological traceability and test standardization/harmonization
- Microbiology – Infectious diseases including COVID 19
- Molecular diagnostics, including CTC and ctDNA
- Neonatal and paediatric laboratory medicine, including prenatal testing
- Nutrition Trace Elements and Vitamins
- Point of Care testing, critical care, emergency medicine
- Precision Diagnostics and Precision Medicine
- Recruitment, Education and Training of workforces in Laboratory Medicine
- Reference Intervals: Direct/Indirect; population vs personal reference intervals
- Regulations and Regulatory Science, including suboptimal tests and post-market follow-up
- Remote monitoring and preanalytical challenges
- Test Evaluation, outcome studies, clinical utility of biomarkers
- Total Test process, including preanalytics, analytics and postanalytics
- Toxicology and TDM
- Others